Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Friedreich Ataxia

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Friedreich Ataxia:

Pubmed Logo
Cardiac manifestations of neuromuscular disorders in children.
Cardiac abnormalities occur in association with many of the neuromuscular...
2nd February, 2010
Children's Hospital at Montefiore and the Albert Einstein College of Paediatr Respir Rev. 2010 Mar;11(1):35-8. Epub 2009 Nov 18.
DOI Direct Link
Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.
BACKGROUND: Friedreich ataxia is a neurodegenerative disease caused by the...
30th January, 2010
Laboratory of Genetics and Molecular Medicine, Instituto de Biomedicina de PLoS One. 2010 Jan 25;5(1):e8872.
DOI Direct Link
Uncommon Features in Cuban Families Affected with Friedreich Ataxia.
This report describes two families who presented with autosomal recessive...
30th January, 2010
Center of Medical Genetics, Holguin, Cuba. Neurosci Lett. 2010 Jan 25.
DOI Direct Link
Antioxidants and other pharmacological treatments for Friedreich ataxia.
BACKGROUND: Friedreich ataxia is a rare inherited, autosomal recessive,...
28th January, 2010
General Practice, Irish College of General Practitioners, Dunlavin, County Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007791.
DOI Direct Link
Autosomal recessive ataxias: 20 types, and counting.
More than 140 years after the first description of Friedreich ataxia,...
14th January, 2010
Outpatient Neurogenetics Clinic, Hospital das Clinicas, School of Arq Neuropsiquiatr. 2009 Dec;67(4):1143-56.

View more research publications.

Press Releases About Friedreich Ataxia:

BioPortfolio Logo
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results 4th February, 2010 Repligen Corporation
WALTHAM, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the third quarter of fiscal year 2010, ended December 31, 2009. Total revenue for the
PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 19th January, 2010 PTC Therapeutics, Inc.
SOUTH PLAINFIELD, N.J., Jan. 19 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of an additional clinical trial of ataluren (PTC124®) in boys and young men with nonsense
Patient Advocates Cite Insurance Caps as Critical Difference in Senate and House Health Care Reform 14th January, 2010 National Organization for Rare Disorders (NORD)
Advocacy groups warn that Senate version of bill would not eliminate caps for millions of Americans WASHINGTON, Jan. 14 /PRNewswire-USNewswire/ -- The National Organization for Rare Disorders and 34
Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 15th December, 2009 Repligen Corporation
WALTHAM, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today announced that the Company has received $731,000 in research funding to support the ongoing development of
Repligen Reports Second Quarter Fiscal Year 2010 Financial Results 5th November, 2009 Repligen Corporation
WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the

BioNews Results for Friedreich Ataxia:

RSS Logo
BioPortfolio Logo
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results
Pharmacy Choice:  Feb 5 2010 12:42AM Matching: friedreich ataxia
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results
Boston Globe:  Feb 4 2010 10:00PM Matching: friedreich ataxia
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results
SmartBrief:  Feb 4 2010 8:24PM Matching: friedreich ataxia
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results
Yahoo! Canada:  Feb 4 2010 2:55PM Matching: friedreich ataxia
Repligen Reports Third Quarter Fiscal Year 2010 Financial Results
Phoenix Business Journal:  Feb 4 2010 2:27PM Matching: friedreich ataxia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Friedreich Ataxia Clinical Trials:

Clinical Trials Logo
Idebenone to Treat Friedreich's Ataxia

Friedreich Ataxia Patents:

USPTO Logo
US Patent No.Title
7456149 ALK7 and myostatin inhibitors and uses thereof
7514099 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7514461 Chroman derivatives
7517669 Gene regulation therapy involving ferritin
7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Friedreich Ataxia scientists - we have details of around 177 individuals working on Friedreich Ataxia .


This page has been viewed 640 times
Recent Search Terms used to find this page: Chem Biol. 2009 Sep 25 16 9 980-9. | fried reich | repligen friedreich s ataxia 2010 | friedreich ataxia pdf | funding for friedreich s ataxia | friedrich ataxia 2009 | friedreich s ataxia video | discovery health friedreich ataxia | funding for Friedreich s Ataxia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Friedreich Ataxia across BioPortfolio, or for Friedreich Ataxia Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.